exceed 20% (Revised) To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results of the Company and its

, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like

-9320 1 Ref: PLC 2019/011 November 13, 2019 Subject: Management Discussion and Analysis Quarter 3 Ended 30 September 2019 To: The President of the Stock Exchange of Thailand Panjawattana Plastic Public

analysis for the three-month period ended September 30, 2019 To: Director and Manager of the Stock Exchange of Thailand Referring to the submission of reviewed financial statements for quarter 3/2019 of Wiik

IDH-AC-000-อส6302/30.00 20 February 2020 Re: Management Discussion and Analysis Operating results for the year ended 31 December 2019 To: President The Stock Exchange of Thailand Overview of the

- Translation - Ref : LPH/SET 2020/012 August 14, 2020 Subject : Clarification on the Operating Results for the 3-month and 6-month period ended June 30, 2020 (Q2/2020) To : President The Stock

Management Discussion and Analysis for the year ended December 31, 2019 Attention The President The Stock Exchange of Thailand Attachment Report and financial statement for the year ended December 31, 2019

www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

หน้า 1 ของ 3 (Translation) No. ACC6702/001 February 28, 2024 Subject: Clarification of operating results for the Annual Year 2023 (Revised) To: The President, The Stock Exchange of Thailand Advanced

investors, which can lead to business expansion, employment, and more competitive edge of local businesses. This translates into the overall economic benefits of the country at large thanks to a close